Nitric Acid

Nitric Acid

SCHEMBL675614

O=[N+]([O-])O.[Ag+].[Ag+].[Ag+].[O-2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ERG11

The experimentally established mechanism targets of Nitric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nitric Acid SCHEMBL5311630 0.95
Nitric Acid SCHEMBL640687 0.95
Nitric Acid SCHEMBL8741913 0.91 CA5A (0.67)
Nitric Acid SCHEMBL9704269 0.90 CA5A (0.80)
Nitric Acid SCHEMBL8853943 0.90
Nitric Acid SCHEMBL9261413 0.90 CA5A (0.80)
Nitric Acid SCHEMBL10456210 0.90
Nitric Acid SCHEMBL343773 0.90
Nitric Acid SCHEMBL2253627 0.90
Nitric Acid SCHEMBL11862492 0.90 CA5A (0.80)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5696276-A Process for preparing 5,8-dihydroxynaphthoquinone derivatives, novel 5,8-dihydroxynaphthoquinone derivatives and their use as anticancer agent KUHNIL PHARMACEUTICAL CO., LTD. (KR) 1997-12-09 US claimed
EP-0662073-A1 PROCESS FOR PREPARING 5,8-DIHYDRONAPHTHOQUINONE DERIVATIVES, NOVEL 5,8-DIHYDRONAPHTHOQUINONE DERIVATIVES AND THEIR USE AS ANTICANCER AGENT KUHNIL PHARMACEUTICAL CO., LTD. (KR) 1995-07-12 EP claimed
WO-1995002572-A1 PROCESS FOR PREPARING 5,8-DIHYDRONAPHTHOQUINONE DERIVATIVES, NOVEL 5,8-DIHYDRONAPHTHOQUINONE DERIVATIVES AND THEIR USE AS ANTICANCER AGENT AHN BYUNG ZUN (KR) 1995-01-26 WO claimed
WO-2026086760-A1 ABSORBENT ARTICLE HAVING ANTIBACTERIAL FUNCTION FOR WOMEN 金佰利(中国)有限公司 2026-04-30 WO disclosed
CN-116162282-A Antibacterial and antiviral structure 京程科技股份有限公司 2023-05-26 CN disclosed
WO-2013075221-A1 COMPOSITIONS AND METHODS FOR TREATING PLANT INFECTIONS BY USING HIGH VALENCY SILVER COMPOUNDS INNOVOTECH, INC. (CA) 2013-05-30 WO disclosed
US-20110275518-A1 Compositions and Methods Comprising High Valency Silver for Increasing Seed Germination MARQUES LYRIAM L 2011-11-10 US disclosed
EP-2162000-A1 METHODS AND COMPOSITIONS COMPRISING HIGH VALENCY SILVER FOR INCREASING SEED GERMINATION Innovotech Inc. (CA) 2010-03-17 EP disclosed
WO-2008148221-A1 METHODS AND COMPOSITIONS COMPRISING HIGH VALENCY SILVER FOR INCREASING SEED GERMINATION INNOVOTECH INC. (CA) 2008-12-11 WO disclosed
US-5696276-A Process for preparing 5,8-dihydroxynaphthoquinone derivatives, novel 5,8-dihydroxynaphthoquinone derivatives and their use as anticancer agent KUHNIL PHARMACEUTICAL CO., LTD. (KR) 1997-12-09 US disclosed
EP-0662073-A1 PROCESS FOR PREPARING 5,8-DIHYDRONAPHTHOQUINONE DERIVATIVES, NOVEL 5,8-DIHYDRONAPHTHOQUINONE DERIVATIVES AND THEIR USE AS ANTICANCER AGENT KUHNIL PHARMACEUTICAL CO., LTD. (KR) 1995-07-12 EP disclosed
WO-1995002572-A1 PROCESS FOR PREPARING 5,8-DIHYDRONAPHTHOQUINONE DERIVATIVES, NOVEL 5,8-DIHYDRONAPHTHOQUINONE DERIVATIVES AND THEIR USE AS ANTICANCER AGENT AHN BYUNG ZUN (KR) 1995-01-26 WO disclosed